Fenfluramine · Phase 3

Comparing fenfluramine with placebo in Rett syndrome.

Study level

The aim, simply

This trial investigates fenfluramine’s efficacy and safety. Spanish sites are listed as recruiting in the consulted source.

Criteria: guidance, not eligibility

The listed age range is 5–35. Diagnosis, mutation and other criteria must be checked in the protocol.

What this cannot tell us

A study record describes research, not a guaranteed benefit or treatment access in your country.

Only the trial team can confirm eligibility. Age and country are not enough: the protocol includes other criteria. Status may also vary by study site.

Centre level

Partial list. A registry listing does not confirm a place. Check directly with the site.